News >

Expert Calls Attention to Treatment-Emergent AEs in Follicular Lymphoma

Caroline Seymour
Published: Wednesday, Jan 29, 2020

Lawrence D. Kaplan, MD

Lawrence D. Kaplan, MD

Immunomodulatory drugs and PI3K inhibitors have shown activity in frontline and relapsed/refractory follicular lymphoma, respectively, and according to Lawrence D. Kaplan, MD, their unique toxicity profiles can help inform treatment decisions.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication